Northera 100 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKG4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,821
Award facts
- Contract value 100% obligated
- $2,821.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,821.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 90 capsules of Northera 100 mg. The award was issued on December 12, 2025, with an ultimate completion date of January 6, 2026, under a firm fixed-price contract structure with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for the Department of Defense.
DMS Pharmaceutical Group holds a single-award IDC designated as contract SPE2DR, valued at $499,999,999 with a completion date of December 31, 2036, which was awarded on November 13, 2025. This contract positions the company as a critical regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables—to support Department of Defense healthcare operations globally. The firm's established performance across numerous delivery orders and its status as a certified woman-owned small business demonstrate its capability to fulfill the specialized pharmaceutical requirements of military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FKKG4?
SPE2DR26FKKG4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FKKG4 worth?
The government has obligated $2,821 on SPE2DR26FKKG4.
Is contract SPE2DR26FKKG4 an order under another contract?
Yes. SPE2DR26FKKG4 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKG4 competed?
The extent of competition for SPE2DR26FKKG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award